Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1986 1
1989 1
1990 1
1993 1
1996 1
1998 1
2012 1
2018 1
2019 1
2021 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Bhatt DL, et al. N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415628 Clinical Trial.
Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Mason RP, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Verma S, et al. Circulation. 2021 Dec 7;144(23):1845-1855. doi: 10.1161/CIRCULATIONAHA.121.056290. Epub 2021 Oct 28. Circulation. 2021. PMID: 34710343 Free article. Clinical Trial.
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
Burger PM, Bhatt DL, Dorresteijn JAN, Koudstaal S, Mosterd A, Martens FMAC, Steg PG, Visseren FLJ; REDUCE-IT Investigators. Burger PM, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):488-499. doi: 10.1093/ehjcvp/pvae030. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38678009 Free PMC article. Clinical Trial.
Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial.
Stewart S, Carrington MJ, Swemmer CH, Anderson C, Kurstjens NP, Amerena J, Brown A, Burrell LM, de Looze FJ, Harris M, Hung J, Krum H, Nelson M, Schlaich M, Stocks NP, Jennings GL; VIPER-BP Study Investigators. Stewart S, et al. BMJ. 2012 Nov 20;345:e7156. doi: 10.1136/bmj.e7156. BMJ. 2012. PMID: 23169801 Free PMC article. Clinical Trial.
Universal correlations between Tc and ns/m (carrier density over effective mass) in high-Tc cuprate superconductors.
Uemura YJ, Luke GM, Sternlieb BJ, Brewer JH, Carolan JF, Hardy WN, Kadono R, Kempton JR, Kiefl RF, Kreitzman SR, Mulhern P, Riseman TM, Williams DL, Yang BX, Uchida S, Takagi H, Gopalakrishnan J, Sleight AW, Subramanian MA, Chien CL, Cieplak MZ, Xiao G, Lee VY, Statt BW, Stronach CE, Kossler WJ, Yu XH. Uemura YJ, et al. Among authors: mulhern p. Phys Rev Lett. 1989 May 8;62(19):2317-2320. doi: 10.1103/PhysRevLett.62.2317. Phys Rev Lett. 1989. PMID: 10039913 No abstract available.
ERA and ONS: power from unity?
Mulhern PJ, Williams HA. Mulhern PJ, et al. Oncol Nurs Forum. 1981 Fall;8(4):43-4. Oncol Nurs Forum. 1981. PMID: 6913050 No abstract available.
12 results